OptimizeRX Corp (NASDAQ: OPRX) stock closed at $14.03 on 12/20/23 after a major increase of 10.2%. Moreover, exceptionally high trading volume at 233% of normal accompanied the advance. Relative to the market the stock has been extremely weak over the last nine months but has risen 42.3% during the last week.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to fall short of the cost of capital, OPRX is expected to continue to be a modest Value Eraser.
OptimizeRX has a current Value Trend Rating of F (Lowest Rating). The Value Trend Rating reflects highly consistent signals from PTR’s two proprietary measures of a stock’s attractiveness. OptimizeRX has a poor Power Rating of 30 and a poor Appreciation Score of 15, resulting in the Lowest Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment